Cargando…
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
Synucleinopathies, such as Parkinson’s disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB), are defined by the presence of α-synuclein (αSYN) aggregates throughout the nervous system but diverge from one another with regard to their clinical and pathological phenotype. T...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244622/ https://www.ncbi.nlm.nih.gov/pubmed/32356200 http://dx.doi.org/10.1007/s00401-020-02157-3 |
_version_ | 1783537613704003584 |
---|---|
author | Van der Perren, Anke Gelders, Géraldine Fenyi, Alexis Bousset, Luc Brito, Filipa Peelaerts, Wouter Van den Haute, Chris Gentleman, Steve Melki, Ronald Baekelandt, Veerle |
author_facet | Van der Perren, Anke Gelders, Géraldine Fenyi, Alexis Bousset, Luc Brito, Filipa Peelaerts, Wouter Van den Haute, Chris Gentleman, Steve Melki, Ronald Baekelandt, Veerle |
author_sort | Van der Perren, Anke |
collection | PubMed |
description | Synucleinopathies, such as Parkinson’s disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB), are defined by the presence of α-synuclein (αSYN) aggregates throughout the nervous system but diverge from one another with regard to their clinical and pathological phenotype. The recent generation of pure fibrillar αSYN polymorphs with noticeable differences in structural and phenotypic traits has led to the hypothesis that different αSYN strains may be in part responsible for the heterogeneous nature of synucleinopathies. To further characterize distinct αSYN strains in the human brain, and establish a structure-pathology relationship, we pursued a detailed comparison of αSYN assemblies derived from well-stratified patients with distinct synucleinopathies. We exploited the capacity of αSYN aggregates found in the brain of patients suffering from PD, MSA or DLB to seed and template monomeric human αSYN in vitro via a protein misfolding cyclic amplification assay. A careful comparison of the properties of total brain homogenates and pure in vitro amplified αSYN fibrillar assemblies upon inoculation in cells and in the rat brain demonstrates that the intrinsic structure of αSYN fibrils dictates synucleinopathies characteristics. We report that MSA strains show several similarities with PD strains, but are significantly more potent in inducing motor deficits, nigrostriatal neurodegeneration, αSYN pathology, spreading, and inflammation, reflecting the aggressive nature of this disease. In contrast, DLB strains display no or only very modest neuropathological features under our experimental conditions. Collectively, our data demonstrate a specific signature for PD, MSA, and DLB-derived strains that differs from previously described recombinant strains, with MSA strains provoking the most aggressive phenotype and more similarities with PD compared to DLB strains. |
format | Online Article Text |
id | pubmed-7244622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-72446222020-06-03 The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies Van der Perren, Anke Gelders, Géraldine Fenyi, Alexis Bousset, Luc Brito, Filipa Peelaerts, Wouter Van den Haute, Chris Gentleman, Steve Melki, Ronald Baekelandt, Veerle Acta Neuropathol Original Paper Synucleinopathies, such as Parkinson’s disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB), are defined by the presence of α-synuclein (αSYN) aggregates throughout the nervous system but diverge from one another with regard to their clinical and pathological phenotype. The recent generation of pure fibrillar αSYN polymorphs with noticeable differences in structural and phenotypic traits has led to the hypothesis that different αSYN strains may be in part responsible for the heterogeneous nature of synucleinopathies. To further characterize distinct αSYN strains in the human brain, and establish a structure-pathology relationship, we pursued a detailed comparison of αSYN assemblies derived from well-stratified patients with distinct synucleinopathies. We exploited the capacity of αSYN aggregates found in the brain of patients suffering from PD, MSA or DLB to seed and template monomeric human αSYN in vitro via a protein misfolding cyclic amplification assay. A careful comparison of the properties of total brain homogenates and pure in vitro amplified αSYN fibrillar assemblies upon inoculation in cells and in the rat brain demonstrates that the intrinsic structure of αSYN fibrils dictates synucleinopathies characteristics. We report that MSA strains show several similarities with PD strains, but are significantly more potent in inducing motor deficits, nigrostriatal neurodegeneration, αSYN pathology, spreading, and inflammation, reflecting the aggressive nature of this disease. In contrast, DLB strains display no or only very modest neuropathological features under our experimental conditions. Collectively, our data demonstrate a specific signature for PD, MSA, and DLB-derived strains that differs from previously described recombinant strains, with MSA strains provoking the most aggressive phenotype and more similarities with PD compared to DLB strains. Springer Berlin Heidelberg 2020-04-30 2020 /pmc/articles/PMC7244622/ /pubmed/32356200 http://dx.doi.org/10.1007/s00401-020-02157-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Van der Perren, Anke Gelders, Géraldine Fenyi, Alexis Bousset, Luc Brito, Filipa Peelaerts, Wouter Van den Haute, Chris Gentleman, Steve Melki, Ronald Baekelandt, Veerle The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies |
title | The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies |
title_full | The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies |
title_fullStr | The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies |
title_full_unstemmed | The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies |
title_short | The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies |
title_sort | structural differences between patient-derived α-synuclein strains dictate characteristics of parkinson’s disease, multiple system atrophy and dementia with lewy bodies |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244622/ https://www.ncbi.nlm.nih.gov/pubmed/32356200 http://dx.doi.org/10.1007/s00401-020-02157-3 |
work_keys_str_mv | AT vanderperrenanke thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT geldersgeraldine thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT fenyialexis thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT boussetluc thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT britofilipa thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT peelaertswouter thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT vandenhautechris thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT gentlemansteve thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT melkironald thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT baekelandtveerle thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT vanderperrenanke structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT geldersgeraldine structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT fenyialexis structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT boussetluc structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT britofilipa structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT peelaertswouter structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT vandenhautechris structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT gentlemansteve structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT melkironald structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies AT baekelandtveerle structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies |